4-[(4-Chloro-2-pyrimidinyl)amino]-benzonitrile

We are 4-[(4-Chloro-2-pyrimidinyl)amino]-benzonitrile CAS:244768-32-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-[(4-Chloro-2-pyrimidinyl)amino]-benzonitrile
CAS.NO:244768-32-9
Synonyms:4-[(4-Chloro-2-pyrimidinyl)amino]-benzonitrile
4-[(4-chloropyrimidin-2-yl)amino]benzonitrile
4-[(4-Chloropyrimidin-2-yl)amino]benzonitrile
4-[(4-Chloro-2-pyrimidinyl)amino]benzonitrile
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 441.0±51.0 °C at 760 mmHg
Molecular Formula C11H7ClN4
Molecular Weight 230.653
Flash Point 220.5±30.4 °C
 
Specification:
Appearance:White to yellow powder
Assay(HPLC):≥99.0%
Any single inpurity:≤0.5%
Moisutre:≤0.5%
Sulfated Ashes:≤0.3%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Rilpivirine(CAS:500287-72-9).

4-[(4-Chloro-2-pyrimidinyl)amino]-benzonitrile


Related News: Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.2-Bromoanthracene CAS:7321-27-9 Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.2-Amino-5-methylhexane CAS:28292-43-5 China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.2-(4-bromo-phenyl)-1(9)H-benzo[d]imidazo[1,2-a]imidazole China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.Developing countries such as China and India have good foundations for undertaking global industrial transfers because of their comparative advantages. With the continuous improvement of China’s fine chemical technology level, the types of products and market shares in China’s undertaking industrial transfer have gradually increased.

Related Products
Product Name
2-Nitrobenzyl alcohol View Details
2-Bromo-6-methylpyridine View Details
5-Cyano-2-fluoropyridine View Details
5-(Bromoacetyl)salicylamide manufacturer 2-(4-Amino-3-nitroanilino)ethanol manufacturer (S)-4-Benzyl-2-Oxazolidinone manufacturer [4-(4-ethylphenyl)phenyl]boronic acid manufacturer 2-[2-[2-(2-ethylhexanoyloxy)ethoxy]ethoxy]ethyl 2-ethylhexanoate manufacturer